Cargando…

Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features

BACKGROUND: Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehrhan, Falk, Hyckel, Peter, Ries, Jutta, Stockmann, Phillip, Nkenke, Emeka, Schlegel, Karl A, Neukam, Friedrich W, Amann, Kerstin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973937/
https://www.ncbi.nlm.nih.gov/pubmed/20942943
http://dx.doi.org/10.1186/1479-5876-8-96
_version_ 1782190848730988544
author Wehrhan, Falk
Hyckel, Peter
Ries, Jutta
Stockmann, Phillip
Nkenke, Emeka
Schlegel, Karl A
Neukam, Friedrich W
Amann, Kerstin
author_facet Wehrhan, Falk
Hyckel, Peter
Ries, Jutta
Stockmann, Phillip
Nkenke, Emeka
Schlegel, Karl A
Neukam, Friedrich W
Amann, Kerstin
author_sort Wehrhan, Falk
collection PubMed
description BACKGROUND: Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab (anti-RANKL antibody)-related ONJ to jaws. Msx-1 is exclusively expressed in craniofacial structures and pivotal to cranial neural crest (CNC)-derived periodontal tissue remodeling. We hypothesised that Msx-1 expression might be impaired in bisphosphonate-related ONJ. The study aim was to elucidate Msx-1 and RANKL-associated signal transduction (BMP-2/4, RANKL) in ONJ-altered and healthy periodontal tissue. METHODS: Twenty ONJ and twenty non-BP exposed periodontal samples were processed for RT-PCR and immunohistochemistry. An automated staining-based alkaline phosphatase-anti-alkaline phosphatase method was used to measure the stained cells:total cell-number ratio (labelling index, Bonferroni adjustment). Real-time RT-PCR was performed on ONJ-affected and healthy jaw periodontal samples (n = 20 each) to quantitatively compare Msx-1, BMP-2, RANKL, and GAPDH mRNA levels. RESULTS: Semi-quantitative assessment of the ratio of stained cells showed decreased Msx-1 and RANKL and increased BMP-2/4 (all p < 0.05) expression in ONJ-adjacent periodontal tissue. ONJ tissue also exhibited decreased relative gene expression for Msx-1 (p < 0.03) and RANKL (p < 0.03) and increased BMP-2/4 expression (p < 0.02) compared to control. CONCLUSIONS: These results explain the sclerotic and osteopetrotic changes of periodontal tissue following BP application and substantiate clinical findings of BP-related impaired remodeling specific to periodontal tissue. RANKL suppression substantiated the clinical finding of impaired bone remodelling in BP- and aRANKL-induced ONJ-affected bone structures. Msx-1 suppression in ONJ-adjacent periodontal tissue suggested a bisphosphonate-related impairment in cellular differentiation that occurred exclusively jaw remodelling. Further research on developmental biology-related unique features of jaw bone structures will help to elucidate pathologies restricted to maxillofacial tissue.
format Text
id pubmed-2973937
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29739372010-11-05 Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features Wehrhan, Falk Hyckel, Peter Ries, Jutta Stockmann, Phillip Nkenke, Emeka Schlegel, Karl A Neukam, Friedrich W Amann, Kerstin J Transl Med Research BACKGROUND: Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab (anti-RANKL antibody)-related ONJ to jaws. Msx-1 is exclusively expressed in craniofacial structures and pivotal to cranial neural crest (CNC)-derived periodontal tissue remodeling. We hypothesised that Msx-1 expression might be impaired in bisphosphonate-related ONJ. The study aim was to elucidate Msx-1 and RANKL-associated signal transduction (BMP-2/4, RANKL) in ONJ-altered and healthy periodontal tissue. METHODS: Twenty ONJ and twenty non-BP exposed periodontal samples were processed for RT-PCR and immunohistochemistry. An automated staining-based alkaline phosphatase-anti-alkaline phosphatase method was used to measure the stained cells:total cell-number ratio (labelling index, Bonferroni adjustment). Real-time RT-PCR was performed on ONJ-affected and healthy jaw periodontal samples (n = 20 each) to quantitatively compare Msx-1, BMP-2, RANKL, and GAPDH mRNA levels. RESULTS: Semi-quantitative assessment of the ratio of stained cells showed decreased Msx-1 and RANKL and increased BMP-2/4 (all p < 0.05) expression in ONJ-adjacent periodontal tissue. ONJ tissue also exhibited decreased relative gene expression for Msx-1 (p < 0.03) and RANKL (p < 0.03) and increased BMP-2/4 expression (p < 0.02) compared to control. CONCLUSIONS: These results explain the sclerotic and osteopetrotic changes of periodontal tissue following BP application and substantiate clinical findings of BP-related impaired remodeling specific to periodontal tissue. RANKL suppression substantiated the clinical finding of impaired bone remodelling in BP- and aRANKL-induced ONJ-affected bone structures. Msx-1 suppression in ONJ-adjacent periodontal tissue suggested a bisphosphonate-related impairment in cellular differentiation that occurred exclusively jaw remodelling. Further research on developmental biology-related unique features of jaw bone structures will help to elucidate pathologies restricted to maxillofacial tissue. BioMed Central 2010-10-13 /pmc/articles/PMC2973937/ /pubmed/20942943 http://dx.doi.org/10.1186/1479-5876-8-96 Text en Copyright ©2010 Wehrhan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wehrhan, Falk
Hyckel, Peter
Ries, Jutta
Stockmann, Phillip
Nkenke, Emeka
Schlegel, Karl A
Neukam, Friedrich W
Amann, Kerstin
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
title Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
title_full Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
title_fullStr Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
title_full_unstemmed Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
title_short Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
title_sort expression of msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973937/
https://www.ncbi.nlm.nih.gov/pubmed/20942943
http://dx.doi.org/10.1186/1479-5876-8-96
work_keys_str_mv AT wehrhanfalk expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures
AT hyckelpeter expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures
AT riesjutta expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures
AT stockmannphillip expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures
AT nkenkeemeka expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures
AT schlegelkarla expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures
AT neukamfriedrichw expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures
AT amannkerstin expressionofmsx1issuppressedinbisphosphonateassociatedosteonecrosisrelatedjawtissueetiopathologyconsiderationsrespectingjawdevelopmentalbiologyrelateduniquefeatures